about
A variant in FTO shows association with melanoma risk not due to BMINucleotide diversity and population differentiation of the melanocortin 1 receptor gene, MC1R.Rare missense variants in POT1 predispose to familial cutaneous malignant melanomaDermoscopy in the diagnosis and management of non-melanoma skin cancers.Melanocortin-1 receptor, skin cancer and phenotypic characteristics (M-SKIP) project: study design and methods for pooling results of genetic epidemiological studiesMC1R variants predisposing to concomitant primary cutaneous melanoma in a monozygotic twin pair.On the interplay of telomeres, nevi and the risk of melanoma.MC1R variants, melanoma and red hair color phenotype: a meta-analysis.MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project.Dermoscopic patterns of acral melanocytic nevi and melanomas in a white population in central Italy.Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families.Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant.MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.Conventional treatment of actinic keratosis: an overview.The Italian Euromelanoma Day: evaluation of results and implications for future prevention campaigns.Knowledge, perceptions and behaviours about skin cancer and sun protection among secondary school students from Central Italy.Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: the experience of two Italian integrated Dermatology/Rheumatology outpatient clinics.Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.Dermatoscopy of basal cell carcinoma: morphologic variability of global and local features and accuracy of diagnosis.The first skin cancer screening day at the Italian parliament: a Euromelanoma initiative.Dermoscopic variability of basal cell carcinoma according to clinical type and anatomic location.Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma.Cutaneous manifestations in Italian kidney transplant recipients.The spectrum of dermatoscopic patterns in blue nevi.Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.Interobserver agreement on dermoscopic features of pigmented basal cell carcinoma.Microabrasion versus microabrasion followed by 15% trichloroacetic acid for treatment of cutaneous hyperpigmentations in adult females.Toxic epidermal necrolysis in a patient with primary myelofibrosis receiving thalidomide therapy.Topical tazarotene 0.05% versus glycolic acid 70% treatment in X-linked ichthyosis due to extensive deletion of the STS gene.CDKN2A and MC1R mutations in patients with sporadic multiple primary melanoma.Variants of the xeroderma pigmentosum variant gene (POLH) are associated with melanoma risk.Dermoscopic features of cutaneous melanoma are associated with clinical characteristics of patients and tumours and with MC1R genotype.Hypoepiluminescence microscopy of pigmented skin lesions: new approach to improve recognition of dermoscopic structures.Constitutional and environmental risk factors for cutaneous melanoma in an Italian population. A case-control study.MC1R, SLC45A2 and TYR genetic variants involved in melanoma susceptibility in southern European populations: results from a meta-analysis.Comprehensive evaluation of allele frequency differences of MC1R variants across populations.Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study.Selective sunscreen application on nevi: frequency and determinants of a wrong sun-protective behaviour.Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents.Conventional vs. daylight methyl aminolevulinate photodynamic therapy for actinic keratosis of the face and scalp: an intra-patient, prospective, comparison study in Italy
P50
Q29417157-C33AD079-38F4-42E2-B6BA-CA8C9202B271Q33327597-718230E5-967A-4808-B62D-D4BB3E979A87Q33751971-703DB89E-772B-4C4E-91E9-1E3C2B17F931Q34245862-039129A7-3765-4B1D-ADE9-256975EB8977Q34365732-0C05C1F0-CF41-432C-B303-B44C7E4EA9A4Q34414747-1A2A9140-B471-4269-85BA-A1F3F00B568EQ34540748-53CF1D37-10AB-442F-8BB3-69453DD33372Q34589701-6BE9A908-1953-49C2-AF5F-30E8907CBF25Q35230315-D7A7014E-765A-419D-B9AB-C8A45331893EQ36597190-2ED1A244-E353-45AA-B3C2-4A7D99E3F5CCQ37415242-6F8E6EB2-50B5-4091-8E54-C5CD82A6B176Q37527319-815E0A3D-EC7D-4D12-A8CB-E9D249BC2981Q37699929-94A47C88-644A-4A65-84AE-212EADD8B2DEQ38308406-F4D30476-7A8F-4B0A-A06E-D5B78B379E27Q39505252-170D2CAA-1F28-4F1C-8F90-478151F93039Q39649528-0ACA32DB-4970-4B33-817F-BDDCABF15A33Q41060904-3418F763-9390-4B98-B731-0875B460DDB8Q41494871-FD860E64-2BD1-46E4-8CDB-73AE8FF83273Q42461344-CC12E29F-34D5-407F-A981-35E972CE38CCQ42463081-088D846F-2B0C-4051-84D7-31D7C0A48F60Q42472062-61005BBA-F893-491B-BADB-8C5B0F321AE3Q42481522-D5FAF667-3EA3-4960-B689-41FC9784D950Q42484474-BAD7A69E-FE64-4356-A480-EAC1335E9A29Q42496557-CD71E4A1-D4F5-47A1-8F4A-210D7DA6AE11Q42517019-E996C6A9-7F63-496D-AB92-0DA2D08AF48DQ42524025-D3256F0A-D5E3-4F22-8DDF-439A451F431FQ44375782-9B4D5409-58B3-445C-B326-75C817077F24Q46217111-90CE8CAE-165A-408F-B9EC-56A078BC9A2BQ46726448-39E2C0FE-6CCA-4318-8872-FFE0013E5D50Q47613053-4BFB6063-0FA3-45BE-A918-4325182CDA54Q47703979-2D10D7A4-3520-4B86-843E-360ED0B54377Q50224889-49F5BEC8-B0AF-4EE4-9784-AF1F6875B50BQ50474463-52C3173F-2374-4490-AFD3-E31ED10A0CB9Q50490263-B876B766-3E44-4C2D-8F0D-50FDCB3D7023Q50514065-81236C68-EB9F-4391-8CCB-8349A4BD54A0Q50706320-567C7F3E-EA92-40D5-B7E4-66FD2D1533A7Q50738743-D57A140D-3843-4BE5-B219-0FB221CCADACQ51272407-42D1C01C-CFBA-4435-AD6C-9BD3D6929B20Q53033887-3882E766-BDB9-45CB-9AFD-CDCE56D145B1Q57111611-0311ADC0-3102-44E1-AE93-95293F01992B
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maria Concetta Fargnoli
@ast
Maria Concetta Fargnoli
@en
Maria Concetta Fargnoli
@es
Maria Concetta Fargnoli
@nl
Maria Concetta Fargnoli
@sl
type
label
Maria Concetta Fargnoli
@ast
Maria Concetta Fargnoli
@en
Maria Concetta Fargnoli
@es
Maria Concetta Fargnoli
@nl
Maria Concetta Fargnoli
@sl
prefLabel
Maria Concetta Fargnoli
@ast
Maria Concetta Fargnoli
@en
Maria Concetta Fargnoli
@es
Maria Concetta Fargnoli
@nl
Maria Concetta Fargnoli
@sl
P106
P1153
6701690192
P21
P31
P496
0000-0002-7249-2556